Psychopharmacology and Psychiatry Updates

Een podcast door Psychopharmacology Institute

Categorieën:

241 Afleveringen

  1. Using Mood Stabilizers in the Geriatric Population

    Gepubliceerd: 23-3-2023
  2. Bright Light Therapy for Perinatal Depression

    Gepubliceerd: 18-3-2023
  3. Using SSRIs in the Geriatric Population

    Gepubliceerd: 13-3-2023
  4. Safety and Efficacy of Duloxetine in Youth With MDD

    Gepubliceerd: 8-3-2023
  5. Challenges in Prescribing Psychotropics to the Geriatric Population

    Gepubliceerd: 3-3-2023
  6. Antidepressants and Vertebral and Hip Risk Fractures

    Gepubliceerd: 26-2-2023
  7. Antidepressants and Mood Stabilizers for Managing Explosive Behavior

    Gepubliceerd: 21-2-2023
  8. Risk of Substance Use Disorders in Children Treated With Psychotropics

    Gepubliceerd: 16-2-2023
  9. FGAs and SGAs for Managing Explosive Behavior

    Gepubliceerd: 11-2-2023
  10. Use of Metformin to Prevent Clozapine-Induced Weight Gain

    Gepubliceerd: 6-2-2023
  11. Managing Acute Aggression in Children and Adolescents

    Gepubliceerd: 1-2-2023
  12. Early Antipsychotic Nonresponse as a Predictor of Nonresponse

    Gepubliceerd: 27-1-2023
  13. Differential Diagnosis of Explosive Behavior

    Gepubliceerd: 22-1-2023
  14. Long-Term Follow-Up of Schizophrenia in Youth

    Gepubliceerd: 17-1-2023
  15. The Serotonin Theory of Depression

    Gepubliceerd: 12-1-2023
  16. SSRIs and Type 2 Diabetes in Children and Adolescents

    Gepubliceerd: 7-1-2023
  17. Tips for Treating Schizophrenia in Children and Adolescents

    Gepubliceerd: 2-1-2023
  18. Physical Activity to Prevent Depression

    Gepubliceerd: 28-12-2022
  19. Use of Antipsychotics for Treating Psychosis in Children and Adolescents

    Gepubliceerd: 23-12-2022
  20. Depression in Adolescents

    Gepubliceerd: 18-12-2022

7 / 13

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site